The Average Percent Volume Reduction in the Lipoma. Baseline and 4 weeks [clinicaltrials_resource:ce2113e07e5e7efd57d330eced86b09c]
Beta-adrenergic agonists and corticosteroid
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
The Average Percent Volume Reduction in the Lipoma. Baseline and 4 weeks [clinicaltrials_resource:ce2113e07e5e7efd57d330eced86b09c]
Beta-adrenergic agonists and corticosteroid
Bio2RDF identifier
ce2113e07e5e7efd57d330eced86b09c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ce2113e07e5e7efd57d330eced86b09c
measure [clinicaltrials_vocabulary:measure]
The Average Percent Volume Reduction in the Lipoma.
time frame [clinicaltrials_vocabulary:time-frame]
Baseline and 4 weeks
description
Beta-adrenergic agonists and corticosteroid
identifier
clinicaltrials_resource:ce2113e07e5e7efd57d330eced86b09c
title
The Average Percent Volume Reduction in the Lipoma. Baseline and 4 weeks
@en
type
label
The Average Percent Volume Red ...... 113e07e5e7efd57d330eced86b09c]
@en